Back
Compare AU
Compare VESG vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Ethically Conscious International Shares Index ETF (VESG) and the S&P US Biotech (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VESG | CURE | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 2,830 | 70 |
Median incremental investment | $990.50 | $678.72 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,395.32 | $2,063.43 |
Average age group | 26 - 35 | > 35 |
Key Summary
VESG | CURE | |
|---|---|---|
Strategy | VESG seeks to track the performance of the FTSE Developed ex-Australia Choice Index (with dividends reinvested) before considering any additional fees, expenses, and taxes. | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | Apple Inc. (5.54 %) Microsoft Corp. (4.67 %) Amazon.com Inc. (2.10 %) | Travere Therapeutics Inc Ordinary Shares (1.79 %) Revolution Medicines Inc Ordinary Shares (1.78 %) Alkermes PLC (1.71 %) |
Top 3 industries | Information Technology (26.14 %) Health Care (16.64 %) Financials (15.14 %) | Health Care (100.00 %) Other (10.24 %) |
Top 3 countries | United States (73.05 %) Japan (6.22 %) Switzerland (2.78 %) | United States (96.62 %) United Kingdom of Great Britain and Northern Ireland (1.35 %) Switzerland (1.13 %) |
Management fee | 0.18 % | 0.45 % |
Key Summary
VESG | CURE | |
|---|---|---|
Issuer | Vanguard | Global X |
Tracking index | FTSE Developed ex Australia Choice Index - AUD | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0.18 % | 0.45 % |
Price | $117.08 | $63.49 |
Size | N/A | $40.308 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.63 % | 5.08 % |
Market | ASX | ASX |
First listed date | 13/09/2018 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VESG | CURE | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 2,830 | 70 |
Median incremental investment | $990.50 | $678.72 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,395.32 | $2,063.43 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
VESG | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VESG | CURE |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |